EP Patent

EP2976063A1 — Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof

Assigned to Pharmathen SA · Expires 2016-01-27 · 10y expired

What this patent protects

The present invention relates to an aqueous pharmaceutical formulation of Moxifloxacin or a pharmaceutically acceptable salt thereof and propylene glycol to be used for the treatment of infections in humans or animals. The present invention also provides a method of preparation o…

USPTO Abstract

The present invention relates to an aqueous pharmaceutical formulation of Moxifloxacin or a pharmaceutically acceptable salt thereof and propylene glycol to be used for the treatment of infections in humans or animals. The present invention also provides a method of preparation of such formulation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2976063A1
Jurisdiction
EP
Classification
—
Expires
2016-01-27
Drug substance claim
No
Drug product claim
No
Assignee
Pharmathen SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.